Clinical Trial Update: High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3) [NA]

View source ↗

Summary

The trial evaluating high-dose ambroxol for pediatric Gaucher disease type 3 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: Agyany Pharma LTD | Conditions: Gaucher Disease, Type 3 | NA | Status: TERMINATED